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Abstract
Duchenne’s muscular dystrophy (DMD) is a severe progressive myopathy caused by mutations in the DMD gene leading to
a deficiency of the dystrophin protein. Due to ongoing muscle necrosis in respiratory muscles late-stage DMD is associated
with respiratory insufficiency and chronic hypoxia (CH). To understand the effects of CH on dystrophin-deficient muscle in
vivo, we exposed the Drosophila model for DMD (dmDys) to CH during a 16-day ascent to the summit of Mount Denali/
McKinley (6194 meters above sea level). Additionally, dmDys and wild type (WT) flies were also exposed to CH in laboratory
simulations of high altitude hypoxia. Expression profiling was performed using Affymetrix GeneChipsH and validated using
qPCR. Hypoxic dmDys differentially expressed 1281 genes, whereas the hypoxic WT flies differentially expressed 56 genes.
Interestingly, a number of genes (e.g. heat shock proteins) were discordantly regulated in response to CH between dmDys
and WT. We tested the possibility that the disparate molecular responses of dystrophin-deficient tissues to CH could
adversely affect muscle by performing functional assays in vivo. Normoxic and CH WT and dmDys flies were challenged with
acute hypoxia and time-to-recover determined as well as subjected to climbing tests. Impaired performance was noted for
CH-dmDys compared to normoxic dmDys or WT flies (rank order: Normoxic-WT < CH-WT. Normoxic-dmDys. CH-dmDys).
These data suggest that dystrophin-deficiency is associated with a disparate, pathological hypoxic stress response(s) and is
more sensitive to hypoxia induced muscle dysfunction in vivo. We hypothesize that targeting/correcting the disparate
molecular response(s) to hypoxia may offer a novel therapeutic strategy in DMD.
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Introduction
Mutations in the DMD gene cause Duchenne muscular
dystrophy (DMD), which is associated with a loss or severe
reduction of the dystrophin protein [1,2,3]. The disease is
characterized by severe progressive muscle degeneration. The
main causes of morbidity and mortality in DMD patients are
cardiac and respiratory muscle failure, the latter estimated to be
responsible for ca. 55 to 90% of the cases [4,5,6,7]. Kyphoscoliotic
deformities of the spinal column and chest wall [8,9,10], reduced
mobility along with ongoing necrosis in the respiratory muscles
contribute to the reduced vital capacity [11,12], hypoxemia and
hypercapnia [8] noted in DMD patients with respiratory
insufficiency. While extremely important from a patho-physiolog-
ical viewpoint, the possible contribution of chronic hypoxia (CH)
to disease progression in DMD patients is not fully understood.
Full length dystrophin is a 427 KDa cytoskeleton associated
protein composed of four distinct structural domains: 1) N-
terminal ‘‘actin binding’’ domain; 2) rod domain consisting of
spectrin-like repeats; 3) cysteine-rich domain; and 4) a carboxyl-
terminal domain [3,13,14]. Dystrophin is associated with a
complex of proteins including the dystroglycans, sarcoglycans,
sarcospan, syntrophins, and dystrobrevins to form the called
dystrophin associated complex (DAC) [13,15]. Apart from a
structural cytoskeletal role, the DAC has been proposed to have an
intracellular signaling role based on its association with acetylcho-
line receptors [16,17], voltage-gated sodium channels [18,19] and
the neuronal isoform of the nitric oxide isoform (nNOS)
[13,15,20,21,22]. Muscles from mice deficient nNOS, either by
a primary nNOS-specific mutation or secondarily by dystrophin-
deficiency, show insufficient production of NO, resulting in
impaired metabolic modulation of a-adrenergic vasoconstriction
[23,24,25]. Consequently, the normally protective vascular
relaxation mechanism is compromised and ischemia has been
noted in dystrophin-deficient limbs. Indeed, changes in vascular
function have been suggested as early and important pathological
changes in DMD muscles [26,27]. Distinct from the localized
hypoxia due to inadequate blood supply noted in ischemia (e.g.
due to inadequate NOS activity) DMD patients have a well-
described ventilatory insufficiency associated with significant
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time) and ensuing systemic hypoxia that would also be predicted to
contribute to patho-physiology [28,29]. These issues are also being
addressed in various DMD animal models. Indeed, the mdx mouse
model has alterations in ventilatory frequency and responses to
hypoxia compared to normal mouse. Additionally exposure to
episodic hypoxia has been noted to exacerbate diaphragmatic
dysfunction in mdx mice [30,31,32].
The dystrophin gene is evolutionarily well conserved and a
number of animal models of DMD have been described including
mouse (mdx) [33,34], dog (GRMD) [35], zebra fish [36], C. elegans
[37] and Drosophila melanogaster (dmDys) [15,38,39,40,41,42] with
mutations existing in the dystrophin gene in vertebrates or
invertebrates genes [15,43]. The Drosophila melanogaster dystrophin
homolog shares 54% sequence identity with human dystrophin,
having conserved motifs in regions that interact with dystroglycan,
syntrophins and dystrobrevins [15]. The organization of the
Drosophila dystrophin gene as is complex as its mammalian
counterparts, having three large isoforms called dystrophin-like
products and three truncated products (Dp186, Dp205 and Dp117)
sharing with the large isoforms the cysteine-rich domains and
carboxy-termini driven by separate internal promoters [15,38].
Two isoforms of syntrophin, a protein that interacts with voltage-
gated sodium channel and nNOS via PDZ domains, is also
expressed in Drosophila melanogaster with a 40% identity with human
counterparts [15]. NOS is another protein constituent complex of
the DAC that is expressed in Drosophila melanogaster. Flies have only
one single gene for NOS, instead of three found in vertebrates. Flies
heterozygous for the NOS deletion show a reduced level of protein
and half the wild type level of NOS activity, while homozygous
deletion in this gene causes lethality in the offspring [44].
Hypoxia is a potent stimulus known to induce changes in
expression of a broad array of genes. Particularly well studied in
mammals are cascades of gene expression occurring via activation
of the Hypoxia Inducible Factor (HIF) transcription factor
pathway. Drosophila responds to hypoxia using the sima and tango
pathways which are similar to HIF-1a and HIF-1b, respectively
[45]. The Sima response to hypoxia has been characterized using
a HRE-LacZ reporter gene for murine lactate dehydrogenase A
(LDA) in transgenic fly embryos. Sima expression increased LDA
after exposing the transgenic flies to 5% O2 for 8 h [46]. The
deletion of the oxygen-dependent degradation domain (conserved
in mammals and Drosophila) induced an increase in Sima protein
levels, similar to that seen under hypoxic conditions, demonstrat-
ing that Sima is oxygen-dependent and regulated by a mechanism
similar to the one described for mammalian HIF-a. The tango gene
product has structural similarities to its mammalian ortholog HIF-
1b protein and is known to binds Sima and other bHLH proteins
[47]. Challenging adult Drosophila to two different lengths of
exposure to hypoxia induces the expression of different sets of
genes [48]. Interestingly, in Drosophila the heat shock proteins
(HSPs) expression was not induced in the mild hypoxia conditions
(5% O2), but was induced during extreme hypoxic conditions (1%
O2), suggesting that these gene expression changes are an adaptive
response to low oxygen levels rather than a response to changes in
exposure time [48].
Drosophila, as other insects, depend on pairs of segmental or
intersegmental muscles located in the dorsal region of each
abdominal segment for several movements, such as ventilation,
oviposition and steering during flight and on direct and indirect
thoracic flight muscles for flight [49,50]. Those muscles show age-
depended degeneration in dystrophic flies and significantly reduce
mobility of the flies [40], suggesting that dystrophic flies may be
subject to poor functional recovery from hypoxic challenges if the
muscles function were compromised by CH. However, the effects
of CH on changes of gene expression and muscle function in
dystrophin-deficient states have not been fully characterized. Here,
we examine the effects of CH in the Drosophila DMD model
(dmDys), using a combination of molecular and functional assays
including Affymetrix GeneChipH-based expression profiling,
qPCR, recovery time after an acute hypoxia challenge and
climbing assays. Our data demonstrate that dystrophin–deficient
flies mount a disparate, pathological response to hypoxia and that
chronic exposure to hypoxia impairs muscle function dystrophin-
deficient flies in vivo.
Materials and Methods
Drosophila stocks
UASdmDysC-term, UASdmDysN-term, v
2;;24B-Gal4 and P-tub-
Gal4 stocks flies were have been previously described [40] and
were maintained at room temperature on standard molasses
media. For expression profiling and functional experiments, we
used dystrophic flies which were obtained by crossing UASdmDysC-
term with P-tub-Gal4 (ubiquitous expression of dsRNA to all tissues
and hence blocks the expression of all short and long dystrophin
isoforms). Additionally, we also used the offspring of UASdmDysC-
term crossed with the driver 24B-Gal4 (mesoderm muscle
expression of dsRNA) and UASdmDysN-term (expression of dsRNA
to block the expression of all short and long dystrophin isoforms)
driven by both drivers for functional experiments. P-tub-Gal4
driver flies were used as gene expression controls. P-tub-Gal4 and
24B-Gal4 drivers were used as controls for functional assays, as
appropriate.
Exposure to Chronic Hypoxia
Flies were exposed to CH during a 16-day ascent of Mount
Denali/McKinley (6194 meters above sea level) with permission
from the National Park Service, USA. All flies were transported by
aeroplane from Philadelphia in thermally insulated vials carried on
person to Kahiltna Glacier at the base of Mount Denali/
McKinley and carried on foot thereafter. Environmental oxygen
pressure (PO2) was calculated from expedition logs (Table S1)
using the formula developed by Prof. John B. West [51]. DmDys
and WT flies were also exposed to CH in laboratory simulations
using PO2 values from Table S1 using a Pegas 4000F gas mixer
(Columbus Instruments, OH, USA). Normoxic flies were kept
breathing at room air in Philadelphia, PA. After exposure to CH,
flies were immediately frozen in RNALaterH (Ambion, Applied
Biosystems, Foster City, CA) and kept frozen till they were
processed for gene expression profiling.
Expression profiling and qPCR validation
Methods were applied as described by manufacturer and
carried out in the laboratory and at the University of Pennsylvania
Microarray Core. The whole body of each fly was individually
homogenized and total RNA was extracted from individual flies
using a RNeasyMini kit (Qiagen, Valencia, CA) and 100 ng were
amplified using NuGen Ovation Amplification Kit (NuGen, San
Carlos, CA). The processed cDNA prepared from 3.75 mgo f
aRNA was hybridized onto GeneChipH Drosophila Genome 2.0
array platform (Affymetrix, Santa Clara, CA). Microarray images
were acquired by GSC 3000 laser scanner (Affymetrix). The raw
intensity values were processed and normalized by CG-RMA
algorithm from raw CEL files and analyzed using GeneSpring GX
V 7.3.1 software (Aligent Technologies, Santa Clara, CA). The
statistical significance (p,0.05), the false discovery rate-FDR (0%),
and the ratio of the changes in expression (2 fold-change cut-off)
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[52]. Microarray results were validated through real time qPCR;
100 ng of total RNA from four individual flies were used to
performed reverse transcriptional reaction using SuperScript First-
Strand, random hexamers protocol (Invitrogen, Carlsbad, CA).
TaqManH Gene Expression assays using MGB probe and primers
(Applied Biosystems, Foster City, CA) for different genes were
performed in a 20 mL final volume (Table S2). The target gene
expressions were normalized using ribosomal protein 11 expres-
sion. All primary microarrays for the dmDys and WT studies
describe above is MIAME compliant and the raw data has been
deposited at the MIAME compliant NCBI’s Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are
accessible through GEO Series accession number GSE15879.
Functional assays
The recovery from severe hypoxia assay was performed as
previously described [53]. Briefly, 100 adult (3–5 days-old) flies/
genotype were placed in 5 different tubes (20 flies/tube) covered by
airpermeableclothand exposed for2 hoursto1%ofFiO2andthen
returned to room air. The time of recovery was recorded once the
fly was able to start to climb up the vial. Each fly was exposed once
to the severe hypoxia assay. The climbing assay was performed to
measure the upward mobility as previously described [40]. Briefly,
five vials from each genotype containing 20 flies each (100 flies in
total) were put into a glass 50 mL tube (12 cm long) and tapped
onceto keep them at the bottom. After 30 seconds, the first tube was
blocked with cotton and then the second tube, which was connected
to the first tube, was connected to the third tube for another 30
second, and so on. The number of flies in each tube was counted
and the climbing index was calculated as weighted average
according to the tube number; the sum of the number of flies in
each tube multiplied by the tube number and divided by the
number of the last tube times the number of the flies in the assay
[54,55]. Each fly was exposed once to the climbing apparatus.
Statistical analysis
All results were expressed as mean 6 SEM. The qPCR results
were analyzed using Relative Expression Software Tool-Multiple
Condition Solves version 2 (REST-MCS) [56]. Kaplan-Meier
test was performed on recovery assay and Kruskall-Wallis test
and Dunn’s multiple comparisons post-test for climbing assays. A
p-value ,0.05 was considered statistically significant.
Results
Gene expression profile
To determine the effect of CH on dystrophin-deficient flies we
screened the Affymetrix Drosophila Genome 2.0 GeneChipH
platform and identified gene expression profiles of four individual
CH-dmDys (Hypoxia protocol provided in Table S1) with four
individual normoxic dmDysflies.Theexpressionlevelsofallprobesets
represented on individual microarrays was plotted on a scatter graph
(Figure 1A) and shows the overall pattern of differences in gene
expression. The overall correlation coefficient (r
2)f o rt h en o r m o x i c
sample data sets compared amongst themselves was 0.98, for the
hypoxic sets 0.97 and the r
2 between the normoxic and hypoxic
sample data sets was 0.86, demonstrating the low intra-variability
amongthesamplesfromnormoxicandhypoxictranscriptomesinthe
dmDys flies. After imposing statistical and 2 fold expression levels
cutoffs, 1281 genes were found to be differentially expressed
(Figure 1A and Table S3), of which 706 genes were significantly
up-regulated (55.1% of the differentially expressed genes) and 575
significantly down-regulated (44.9% of the total differentially
expressed). The genes for lysosome X and CG12057 were the most
up-regulated (498.87 fold) and down-regulated (-624.6 fold),
respectively. Figure 1B shows the heat map representation of
hierarchical clustering of the profile. Branch-length analysis of data
(Figure1B) demonstrated that the four CH-dmDys samplesweremore
similar to each other than to normoxic-dmDys samples and vice versa,
further demonstrating that the gene expression profiles between CH-
and normoxic-dmDys were significantly different from each other.
Similar results were obtained using principal component analysis
(data not shown). To independently validate the microarray analysis,
we randomly chose five out of the top 10 differentially expressed
genes (Table S4) and analyzed them by qPCR from biologically
independent samples using TaqManH Gene Expression probe sets.
All five genes showed significant fold-changes in a direction
concordant to that as observed in the microarray, confirming the
validity of the results (Figure 2).
In order to understand the relationship between the genes
differentially expressed and pathways involved we analyzed the
differentially expressed genes list by clustering of functional
annotation of the main biological processes using DAVID. To
increase stringency, we only selected the enriched groups in which
all annotations were significantly clustered (p,0.05). The most
enriched categories among the up-regulated genes were amino
acid, carboxylic acid and organic acid metabolic processes and
among the down-regulated genes were regulation of protein
kinase, transferase and kinase activities (Table S5).
H a v i n ge s t a b l i s h e dt h eg e n ee x p r e s s i o np r o f i l eo fdmDys subjected to
CH we also determined the gene expression profile of CH wild type
(WT) Drosophila in order to compare hypoxia-induced gene changes in
dmDys to those in WT. We screened the Affymetrix Drosophila
Genome 2.0 GeneChipH platform and identified gene expression
profiles of four individual CH-WT (Hypoxia protocol provided in
Table 1) flies with four individual normoxic WT flies. The expression
levels of all probe sets represented on individual microarrays was
plotted on a scatter graph (Figure 3A) and shows the overall pattern of
differences in gene expression. The overall r
2 for the normoxic sample
data sets compared amongst themselves was 0.98, for the hypoxic sets
0.93 and the r
2 between the normoxic and hypoxic sample data sets
was 0.93, demonstrating the low intra-variability among the samples
from normoxic and hypoxic transcriptomes in the WT flies. After
imposing statistical and 2 fold expression levels cutoffs, 56 genes were
found to be differentially expressed (Figure 3A; Table S6); 55 were up-
regulated and only one gene was down-regulated. Figure 3B shows the
heat map representation of hierarchical clustering of the entire profile.
Branch-length analysis of data (Figure 3B) demonstrated that the four
CH-WT samples were more similar to each other than to normoxic-
WT samples, and vice versa demonstrating that the gene expression
profiles between CH- and normoxic-WT were significantly different
from each other. Similar results were obtained using principal
component analysis (data not shown). To independently validate the
microarray analysis randomly chose five (4 up-regulated and 1 down-
regulated) out of the top 10 differentially expressed genes (Table S7)
and analyzed them by qPCR from biologically independent samples
using TaqManH Gene Expression probe sets. All five genes showed
significant fold-changes in a direction concordant to that as observed
in the microarray, confirming the validity of the results (Figure 4).
Functional clustering analysis using DAVID was performed only on
the up-regulated gene list, and show an enrichment of the category
related with response to stress (Table S8).
Comparing hypoxia-induced gene changes in dmDys and WT
flies, we found 20 common genes (Figure 5), of which 10 genes
were up-regulated in both profiles (CH-dmDys and CH-WT), and
10 genes were discordantly regulated in that they were down-
regulated in CH-dmDys but up-regulated in CH-WT. Interestingly,
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(Table 1). To determine the changes in gene expression caused
only by the absence of dystrophin, we compare the gene
expression profiles obtained from dmDys vs. WT, both under
normoxic conditions. In this analysis, we found 208 genes
differentially expressed, in which 114 genes were up-regulated
Figure 1. Differential expression of transcripts in dmDys exposed to chronic hypoxia. A) Scatter graph of log10 expression values of
differentially expressed genes. Each individual point on the scatter graph represents a probe set that met the statistical and two-fold differential
expression cut offs used in this study. Parallel lines show the 2 fold cutoff. Genes lying furthest off the diagonal exhibit greatest expression differences
between CH-dmDys and normoxic dmDys. The arrows indicate representative differentially expressed genes used for validation. B) Graphical
representation of all 1281 transcripts that were differentially expressed in CH-dmDys and normoxic dmDys. The four CH-dmDys and four dmDys
GeneChip data sets can be seen to cluster into two distinct groups based on correlation of gene expression pattern. The branches lengths for CH-
dmDys and dmDys subtrees seen at the top are based on normalized raw data of all transcripts and quantitatively demonstrate that the four samples
are closely related to each other, as are the four dmDys samples. Each horizontal colored bar represents one probe set, and the color of the bar
determines the degree of expression (red = up-regulated genes; blue = down-regulated genes; yellow = no differentially regulated genes).
doi:10.1371/journal.pone.0013450.g001
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differentially expressed genes were amplified using cDNA from four independent RNA preparations and analyzed by qPCR. Graph shows concordant
changes of gene expression levels for various genes noted on microarrays (unfilled bars) and validated by qPCR (filled bars).
doi:10.1371/journal.pone.0013450.g002
Table 1. Intersection gene list comparing profiles of WT and dmDys flies exposed to CH.
AFFY_ID Gene Name wild type dmDys
AFFX-r2-Dros-Act5C-5_x_at ACTIN 5C 4.11 124.77
1641681_s_at CG5288-PA, isoform A 2.50 3.62
1633637_at CG17026-PA 4.01 6.16
1633197_at CG32024-PA 2.90 41.94
1628699_at larval serum protein 1 6.36 4.76
1637833_at CG30095-PA 23.22 7.47
1637833_at juvenile hormone esterase 3.57 8.21
1623675_at odorant-binding protein 99B 23.21 27.77
1634529_at CG3290-PA 6.11 21
1636620_s_at CG15095-PB, isoform B 2.86 2.65
1638484_at heat shock protein 67BC 5.98 214.63
1635044_at heat shock protein 26 5.47 212.12
1638872_at heat shock protein 68 4.82 224.55
1629061_s_at heat shock protein 22 4.94 29.98
1641055_at heat shock protein 23 3.24 27.31
1628117_at heat shock protein 27 3.03 25.63
1634187_x_at alpha gamma-element 4.63 218.95
1626821_s_at heat shock protein 70BA 11.40 22631.58
1633770_at GH10821P 4.61 23.54
1639571_s_at heat shock protein 70AB 7.34 22173.91
The AFFY ID, gene name and fold change values obtained from microarray analysis.
doi:10.1371/journal.pone.0013450.t001
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among the 114 up-regulated genes we found 8 Hsp genes, which
were the same as those that were down-regulated in dmDys exposed
to CH, as described above (Hsp23, Hsp26, Hsp27, Hsp67Bb,
Hsp68, Hsp70Aa, Hsp70Bbb and Hsp70Bc).
The gene expression of two categories were analyzed in order to
ask whether hypoxia was the major abiotic variable between the
hypobaric hypoxic (Mount Denali) experiments and normobaric
hypoxic experiments under controlled abiotic parameters. As
shown on Table 2, the genes related to response to stress (Hsp23,
Hsp26, Hsp27, Hsp67, Hsp67BC and Hsp68) showed an overall
concordant down-regulation of expression in dmDys flies under
both, normobaric or hypobaric hypoxic conditions. Moreover, the
genes related to carbohydrate metabolism (Hexokinase C,
Mannosidase 1, CG5288 and CG17026-PA) were consistently
up-regulated in dmDys exposed to normobaric or hypobaric
hypoxia. We also studied the gene expression level of two genes
that were also present in both hypobaric and normobaric gene
expression profiling. Odorant binding protein 99B (developmental
process) and Juvenile hormone esterase (lipid metabolism) also
showed a similar tendency of expression in both types of hypoxia.
These results suggest that long term exposure of hypoxia was the
major abiotic variable in the experimental paradigms.
Functional Assays
Hypoxia-recovery assay. In order to study functional effects
of hypoxia in the absence of dystrophin, and address the possibility
that the disparate molecular responses of dystrophin-deficient tissues
Figure 3. Differential expression of transcripts in WT exposed to chronic hypoxia. A) Scatter graph log10 expression values of differentially
expressed genes. Each individual point on the scatter graph represents a probe set that met the statistical and two-fold differential expression cut
offs used in this study. Parallel lines show the 2 fold cutoff. Genes lying furthest off the diagonal exhibit greatest expression differences between CH-
WT and normoxic WT. The arrows indicate representative differentially expressed genes used for validation. B) Graphical representation of all 56
transcripts that were differentially expressed in CH-WT and normoxic WT. The four CH-WT and four WT GeneChip data sets can be seen to cluster into
two distinct groups based on correlation of gene expression pattern. The branches lengths for CH-WT and WT subtrees seen at the top are based on
normalized raw data of all transcripts and quantitatively demonstrate that the four samples are closely related to each other, as are the four WT
samples. Each horizontal colored bar represents one probe set, and the color of the bar determines the degree of expression (red = up-regulated
genes; blue = down-regulated genes; yellow = no differentially regulated genes).
doi:10.1371/journal.pone.0013450.g003
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recovery and climbing assays. In the hypoxia-recovery assay we
quantified the recovery time in seconds of controls, dmDys and CH-
dmDysflies todetermine whether a)dystrophinplays a role inrecovery
after being challenged by acute hypoxia and b) prior exposure to CH
is detrimental to recovery from an acute hypoxic challenge. The WT
(controls) had a faster median recovery time (c. 400 sec) in
comparison to a slower median time to recovery (c.600 sec) of the
dmDysC-term/P-tub-Gal4 flies. This result showed a significantly
impaired recovery by dmDysC-term/P-tub-Gal4 flies after being
challenged by acute severe hypoxia exposure (Figure 6). The
median time to recover from the acute severe hypoxia was further
increased in CH-dmDys (Table 3), demonstrating that prior exposure
to CH is detrimental to recovery from an acute hypoxic challenge.
ThisresultshowstheroleplayedbydystrophininDrosophilato normal
behavioral recovery from hypoxia. Similar results were observed
using muscle-specific driver (Figure S1-A), demonstrating that
dystrophin expressed in muscle contributes to functional recovery
after an acute hypoxic challenge. To obviate the possibility of
alternate promoter usage we repeated the assays with both the
transgenic drivers using N-terminal mutants of dystrophin and
obtained similar results (Table 3; Figure S1-B and S1-C).
Climbing assay. We further analyzed the functional effects
of hypoxia by subjecting the flies to climbing assays to test mobility
of dmDys, as described previously [40]. In these assays, we
quantified the climbing index of WT vs. dmDys and vs. CH-dmDys
as an in vivo indirect measurement of innate muscle function to
determine whether a) dystrophin plays a role in climbing mobility
and b) prior exposure to CH is detrimental to mobility to climb in
flies lacking dystrophin. As shown in Table 4, WT controls had a
climbing index of c. 49%. In comparison to the controls, the
dmDysC-term/P-tub-Gal4 flies lacking dystrophin had a significantly
impaired climbing index (c.11%), demonstrating the role played
by dystrophin in terms of climbing ability (Figure S2-A). The
climbing index even poorer in CH-dmDys (c. 8%), suggesting that
prior exposure to CH is detrimental to innate muscle function as
measured by the climbing index. These experiments were also
performed using the strains and drivers described above and
provided results similar to those obtained using the hypoxia
recovery assay for dmDysC-term (Figure S2-B) and dmDysN-term
(Figure S2-C and S2-D) genotypes (Table 4). Taken together these
data demonstrate that dystrophin plays an important functional
role in muscle and that CH further exacerbates the impaired
function in the absence of dystrophin.
Discussion
In this study we investigated the effects of CH upon gene
expression at the level of the transcriptome and functional activity
Figure 4. Validation of differential expression of five genes detected on WT profile by real time RT-PCR. Five out of top 10 differentially
expressed genes were amplified using cDNA from four independent RNA preparations and analyzed by qPCR. Graph shows concordant changes of
gene expression levels for various genes noted on microarrays (unfilled bars) and validated by qPCR (filled bars).
doi:10.1371/journal.pone.0013450.g004
Figure 5. Venn diagram of comparison gene expression profile
between dmDys and WT flies exposed to CH. From 1281
differentially expressed genes in dmDys and 56 in WT flies, 20 genes
were found to be in common; among them, 10 genes were
concordantly regulated in both profiles, while 10 were discordantly
regulated in the profiles.
doi:10.1371/journal.pone.0013450.g005
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GeneChipH-based expression flies were able to identify and
analyze molecular responses to hypoxia at the level of the
transcriptome in dmDys and WT flies (Figure 1 and 3 Table S3, S4,
S6 and S7), as well as independently validate transcriptome level
changes by qPCR (Figure 2 and 4, & Table 1 and 2). The
molecular responses to CH in WT and dmDys flies were found to
be disparate in terms of the ability of the respond to the stresses of
Table 2. Validation of changes in expression levels of genes encoding heat shock proteins carbohydrate metabolism,
developmental process and lipid metabolism in dmDys exposed to hypobaric and normobaric CH.
Category Gene CH-dmDys-Hypobaric CH-dmDys-Normobaric
Response to stress Hsp 23 27.3460.04* 21.2360.16
Hsp 26 27.7460.023** 22.4560.28*
Hsp 27 26.2460.05*** 22.6660.11***
Hsp67 2624.2660.01*** 219.5560.02**
Hsp67BC 264.8460.01 *** 214.4160.01***
Hsp68 289.0860.03*** 26.9960.05*
Carbohydrate Metabolism Hexokinase C 4.6461.12* 4.7460.70***
Mannosidase 1 3.8461.01* 4.1661.45*
CG5288 5.4261.48* 2.2560.53 **
CG17026-PA 6.1662.56 * 6.0062.28*
Developmental process Odorant binding protein 99B 8.5763.24 ** 1.8460.63*
Lipid metabolism Juvenile hormone esterase 1.3760.31 1.1860.41
Concordant decreases in levels of genes encoding HSP expression and increases in genes encoding carbohydrate metabolism, developmental process and lipid
metabolism were noted in dmDys exposed to both hypobaric or normobaric hypoxia compared to normoxic dmDys. Values are mean 6 SD.
*p,0.05.
**p,0.01;
***p,0.001 vs. normoxic dmDys.
doi:10.1371/journal.pone.0013450.t002
Figure 6. Time of recovery from severe hypoxic challenge assay. The dmDysC-term flies were exposed either to normoxia (triangle) or CH
(square) following the hypoxia protocol. Then, the flies were exposed for 2 hours under 1% FiO2 and then to room air. The starting time was
considered as the moment when the normoxia was reestablished and a complete recovery was considered when the fly climbed the vial. The driver
P-tub-Gal4 was used as control. Five vials from each genotype were used containing 20 flies per vial. The dotted line shows the median recovery time
in seconds of the assay. *** p,0.001 dmDys vs. WT. # p,0.05 from CH-dmDys vs. normoxic dmDys.
doi:10.1371/journal.pone.0013450.g006
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profiling on dmDys exposed to hypobaric hypoxia (Mount
McKinley/Denali), we do not discount the possibility that several
abiotic factors (such as temperature, humidity, barometric
pressure, etc.) could have some influence in the profile.
Nevertheless, we observed that the major changes in the gene
expression profiling were also observed in controlled situations
(normobaric hypoxia, Table 2), suggesting the major abiotic factor
is related to hypoxia. Using functional assays we found that
dystrophin plays an important functional role in muscle and that
CH further exacerbates the impaired function in the absence of
dystrophin (Figure 6 and Tables 3 & 4). Taken together our data
demonstrate that dystrophin–deficient flies mount a disparate,
pathological response to hypoxia and that chronic exposure to
hypoxia impairs muscle function dystrophin-deficient flies in vivo.
Drosophila melanogaster models are being increasingly used to better
understand the patho-physiology of human diseases. Over the last
decade, this model has been used to study the mechanisms of
hypoxia and its physiological effects, which has given enormous
insight into angiogenesis, tumor formation, metabolism, and stress
mechanisms [57,58,59,60,61]. More recently, Drosophila has been
used to understand the molecular and cellular pathogenesis of
DMD [38,40,41,42]. Despite hypoxia and respiratory failure being
important features of DMD disease, a number of open questions
exist regarding the patho-physiological responses to hypoxia in
muscle functioning and dystrophin-deficiency in vivo. Recently,
severalgroupshavebeenstudyingthe effectofthe lackofdystrophin
in Drosophila melanogaster. These studies have increased our
understanding of the cellular role of dystrophin and its complex in
the muscle and other tissues. Additionally, identify the consequence
of dystrophin deficiency on the function of the central nervous
system, photo-receptor path-finding, neuromuscular junction and
muscle integrity [40,41,42,62]. The availability of the Drosophila
model of DMD also allowed us to addressthe effect of CH on global
gene expression and muscle function in the Drosophila DMD model.
It is currently well established that CH leads to robust changes
in overall gene expression in Drosophila, albeit using different time
scales, oxygen levels and ages of flies compared to our studies
[48,63,64]. Using adult WT flies, Liu et al (2006) also showed that
different intensities of hypoxia or lengths of exposure can induce
different patterns of gene expression. For extreme hypoxia at 0.5%
O2 for 1 hour, 20 genes were differentially expressed, increasing to
79 genes when the time was increased up to 6 hours. The number
of differentially expressed genes decreased to 47 genes after the
adult WT flies were exposed for 6 hours to lesser (5% O2) degrees
of hypoxia [48]. These data are consistent with our results where
we found 56 genes differentially expressed in response to c. 2
weeks of 13% CH (Table S6). Interestingly dmDys flies had a
greater magnitude of response in that 1281 genes were
differentially expressed in response to CH (Table S3). Collectively,
these data suggest that exposing dmDys to CH in contrast to
exposing WT flies to CH induces a significant change on gene
expression in order adapt the new cellular needs induced by
stresses of flies lacking dystrophin. Supporting this notion the
analysis of the most enriched clustering categories from CH-dmDys
up-regulated genes list revealed an increase in transcript levels of
genes related to protein metabolism, biosynthesis, and apoptosis.
Additionally, the most enriched categories from the down-
regulated gene list were response to stress, the cell cycle and
regulation of protein kinase activity. Conversely, the response to
stress category (containing the Hsp genes) in WT flies exposed to
CH was the only enriched category identified from the up-
regulated gene list (Table S8). Interestingly, only 20 differentially
expressed genes were identified in common between CH-WT and
CH-dmDys profiles, out of which, half were dysregulated, being
down-regulated in dmDys flies exposed to CH.
Members of the Hsp gene family were prominent amongst the
genes that were regulated in a disparate manner in dmDys exposed
to CH (Figure 5). Comparing this study with previous reports
[48,65], we found that the HSP family gene was the most common
differentially expressed genes in the WT profile (Hsp22, Hsp23,
Hsp26, Hsp27 Hsp67Bc, Hsp68, Hsp70Ba and Hsp70AB), which
were also down-regulated in the CH-dmDys gene expression profile
and demonstrate the inability of the dmDys flies to mount an
efficient response to the stress of hypoxia. The Hsp pathway is well
Table 3. Hypoxia recovery challenge assay in WT and dmDys
flies previously exposed to normoxia or CH.
GENOTYPE TIME (s) P-VALUE
P-tub-Gal4 390
CH- P-tub-Gal4 410 ns
24B-Gal4 400
CH-24B-Gal4 410 ns
dmDysC-term/P-tub-Gal4 620 ***
CH- dmDysC-term/P-tubGal4 840 ***
dmDysC-term/24B-Gal4 600 ***
CH- dmDysC-term/24B-Gal4 770 *** #
dmDysN-term/P-tub-Gal4 520 *** #
CH-dmDysN-term/P-tub-Gal4 660 ***
dmDysN-term/24B-Gal4 590 ***
CH- dmDysN-term/24B-Gal4 750 ***
After acute hypoxic exposure (FiO2 1% for 2 h), the time was recorded when the
flies returned to normoxia until they climbed the vial. Median, n=100.
***p,0.001 dmDys vs. WT.
# p,0.05 dmDys vs. CH-dmDys.
doi:10.1371/journal.pone.0013450.t003
Table 4. Climbing assay in dmDysC-term exposed either to
normoxia or CH.
GENOTYPE CLIMBING INDEX (%) P-VALUE
P-tub-Gal4 49.8167.20
CH- P-tub-Gal4 38.7761.60 ns
24B-Gal4 30.3669.38
CH-24B-Gal4 38.7469.45 ns
dmDysC-term/P-tub-Gal4 11.7865.37 ***
CH-dmDysC-term/P-tubGal4 8.0263.65 **
dmDysC-term/24B-Gal4 3.7062.14 *
CH-dmDysC-term/24B-Gal4 2.0061.35 **
dmDysN-term/P-tub-Gal4 37.7965.27 **
CH-dmDysN-term/P-tub-Gal4 15.5762.37 **
dmDysN-term/24B-Gal4 12.5067.98 ns
CH-dmDysN-term/24B-Gal4 5.7862.69 *
Five vials from each genotype containing 20 flies in each vial were used. The
results were compared to WT. Mean 6 SEM, N=100;
*P,0.05;
**P,0.01;
***P,0.001 dmDys vs. driver.
doi:10.1371/journal.pone.0013450.t004
Chronic Hypoxia in DMD Flies
PLoS ONE | www.plosone.org 9 October 2010 | Volume 5 | Issue 10 | e13450studied in terms of response to stresses such as hypoxia. Typically
cellular responses to hypoxic stress include an increase of Hsp
RNA and protein expressions are mediated in part by the Heat
Shock Factor (HSF) transcription factor [66,67]. Under various
stresses the inert HSP-HSF complex is thought to disassociate
allowing HSF to up-regulate Hsp. Additionally, it has been shown
that under hypoxic conditions, HSF is actively transcribed by HIF
due to the presence of two HRE sequences on intronic region of
HSF gene [65]. In mammals Hsps have been classified into five
families according to their molecular weight (small HSP, HSP60,
HSP70, HSP90 and HSP100). HSPs provide tolerance not only to
hyperthermia, but also resistance to hypoxia, ischemia, inflamma-
tion, among other stress conditions. Moreover, as chaperones,
HSPs have other functions such as aiding correct protein folding,
regulating protein degradation and in translocation of proteins to
different cellular compartments [68]. In our studies we detected
genes from the major Hsp families: the small HSP (Hsp22, Hsp23,
Hsp26 and Hsp27) and HSP70 (Hsp67BC, Hsp70AB, Hsp70BA
and Hsp70BBB) families [69]. Recently, it has been shown that
sustained hypoxia (FiO2 =1.0% for 2 h) increases the expression
of Hsp 70 family, Hsp68 and Hsp23. This increase was associated
with a higher survival rate of Drosophila exposed to prolonged
hypoxic paradigm (FiO2 =1.5% for 7 days). Mutants that have no
copies or few copies of mRNA of Hsp70 were unable to survive,
while over expression of Hsp70 on specific parts of the brain
(mushroom body and antennal lobes) or heart (cardial cells,
pericardial cells and hemocytes) significantly increased survival in
CH [70]. However, the mechanisms and signaling pathways for
protection given by high levels of expression of HSP still remain
unknown. Interestingly, increased expression of HSP90 has been
described in DMD patients muscle samples compared to control
[71]. Moreover, the increased expression of HSP90 has been
observed in regenerating fibers while increased levels of HSP72,
HSP73 and HSP60 has been noted in hypercontracted fibers [72].
However, a reduction in expression of HSP20, GRP75 (HSP-70
family) and HSP90 has been reported using proteomic analysis of
the diaphragm of the mdx mouse model of DMD; the same analysis
also revealed an increased expression of cvHSP and HSP110 [73].
In view of the disparate responses of HSP in the CH-dmDys flies
found in this study, it may be beneficial to re-evaluating the issue
of HSP in clinical biopsies with regards to presence or absence of
hypoxemia.
When comparing our hypobaric hypoxia CH-dmDys gene
expression profiling data to data sets of responses to hypoxic
exposure of mammalian muscle (See Lundby et al.)[74], two genes
were found in common. The PDGF-and-VEGF related factor 2
was down-regulated 10.66 times and Hexokinase C up-regulated
2.78 times. In the comparison between normoxic WT and CH
WT flies, the insulin-like peptide 5 was up-regulated 6.59 times.
Finally, in the gene list of normoxic dystrophic flies compared to
normoxic WT, the carbonic anhydrase 2 was up-regulated 2.67
times was found. In terms of functional similarity of genes
described in mammals with those found in our study in CH-
dmDys, we found significant enriched clusters of up-regulated
genes related with amino acid metabolism, chitin-related metab-
olism, cell cycle process and among the most down-regulated
genes, we found the response to stress. For WT flies, the most
significant enriched cluster is related to response to stress. These
comparisons showed that the CH protocol used in our study
induces different clusters of genes and differential responses
compared to CH protocols using mild but prolonged hypoxic
challenge.
It is well known that hypoxia has a profound effect on muscle
performance in mammals [75,76,77,78,79] and hypoxia is able to
alter behavioral and muscle function in flies [40,53,63,64].
Additionally, it has also been well documented that the absence
of dystrophin causes both functional and behavioral impairments
[40,41,42,80]. In our studies, we found that CH impaired both the
ability to recover from hypoxia and climbing mobility perfor-
mance in WT and dmDys flies. Importantly the mobility in either
recovery from acute hypoxia exposure or the mobility to climb in
flies lacking dystrophin was more pronounced (Tables 3 and 4).
Furthermore, dmDys flies where we had ablated dystrophin only in
the muscle, performed extremely poorly compared to WT,
suggesting that muscle was an important functional target of the
CH. Taken together the results would suggest that dystrophin
plays an important functional role in muscle and that CH
exacerbates impaired function in the absence of muscle dystro-
phin. The presence of short dystrophin isoforms (DP186, DP205
and DP117) in dmDysN-term mutants would also be expected to
partially help recovery of muscle function and protection from
hypoxic damage by facilitating somatic muscle contraction and
hence ventilation [50,81,82], once the dmDys flies were returned to
normoxia. This notion is supported by previous studies that have
showed age-dependent muscle degeneration, loss of fiber density
and vacuolization in of the indirect muscle fly [40] and increases in
areas devoid of myofibrils in dmDys mutants fly hearts [80].
In conclusion, here we identified the distinct gene expression
profiles of WT and dmDys flies exposed to hypoxia. We
demonstrated that CH induces a disparate molecular response in
the absence of dystrophin in vivo. The HSP pathway was identified
as dysregulated in the response mounted by flies lacking
dystrophin to hypoxia. The lack of a robust HSP induction in
response to hypoxia may contribute to the functional impairment
noted in the flies lacking dystrophin. As the HSP response is
evolutionarily conserved, we suggest that this pathway may be of
consequence in advanced DMD patients with a severe degree of
hypoxemia. We hypothesize that targeting and correcting genes
involved in the disparate molecular response to hypoxia may be a
novel therapeutic strategy in DMD.
Supporting Information
Table S1 Expedition log book for Mount Denali/McKinley
Hypoxia Research Expedition. Information obtained during the
ascent and summit of Denali, June 1st to June 16th of 2007. The
oxygen pressure (PO2) was calculated from the barometric
pressure. Load Ferry (LF) refers to a climb with loads to the
specified highpoint and return to the starting point. The time of
exposure is indicated in brackets.
Found at: doi:10.1371/journal.pone.0013450.s001 (0.02 MB
PDF)
Table S2 Genes tested by qPCR for microarray validation.
Name, catalog number from Applied BiosystemsH and REFSEQ
from each gene used on validation of microarray study. The last
gene is the housekeeping gene used.
Found at: doi:10.1371/journal.pone.0013450.s002 (0.01 MB
PDF)
Table S3 DmDys gene list.
Found at: doi:10.1371/journal.pone.0013450.s003 (0.16 MB
XLS)
Table S4 List of top 10 differentially expressed genes detected in
dmDys exposed to CH profiling. Affy ID, name, FlyBase ID and
fold change is shown for each gene.
Found at: doi:10.1371/journal.pone.0013450.s004 (0.02 MB
PDF)
Table S5 Functional Annotation from dmDys exposed to CH.
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XLS)
Table S6 WT gene list.
Found at: doi:10.1371/journal.pone.0013450.s006 (0.02 MB
XLS)
Table S7 List of top 10 differentially expressed genes expression
detected in WT flies exposed to CH profiling. Affy ID, name,
FlyBase ID and fold change is shown for each gene.
Found at: doi:10.1371/journal.pone.0013450.s007 (0.01 MB
PDF)
Table S8 Functional Annotation from WT exposed to CH.
Found at: doi:10.1371/journal.pone.0013450.s008 (0.02 MB
XLS)
Table S9 Nomoxic dmDys vs. WT gene list.
Found at: doi:10.1371/journal.pone.0013450.s009 (0.05 MB
XLS)
Figure S1 Time of recovery from severe hypoxic challenge
assay. The dmDysC-term and dmDysN-term driven by either P-
tub-Gal4 or 24B-Gal4 were exposed either to normoxia (triangle)
or CH (square) following the hypoxia protocol. Then, the flies
were exposed for 2 hours under 1% FiO2 and then to room air.
The starting time was considered as the moment when the
normoxia was reestablished and a complete recovery was
considered when the fly climbed the vial. The driver P-tub-Gal4
or 24B-Gal4 was used as control. Five vials from each genotype
were used containing 20 flies per vial. The dotted line shows the
median recovery time of the assay. *** p,0.001 dmDys vs. drivers.
# p,0.05 from CH-dmDys vs. normoxic dmDys.
Found at: doi:10.1371/journal.pone.0013450.s010 (0.05 MB
PDF)
Figure S2 Climbing index of dmDys exposed to CH. The
dmDysC-term and dmDysN-term driven by either P-tub-Gal4 or
24B-Gal4 were exposed either to normoxia (red) or CH (blue)
following the hypoxia protocol. Five vials from each genotype
containing 20 flies in each vial were used. DmDysC-term mutation
was driven by driven by tubulin (A) or muscle-specific driver (B),
and dmDysN-term driven by tubulin (D) or muscle-specific (E).
The driver P-tub-Gal4 or 24B-Gal4 was used as control. The
starting time was considered as the moment when the normoxia
was reestablished and a complete recovery was considered when
the fly climbed the vial. Mean 6 SEM, n=100; * p,0.05; ** p,
0.01; *** p,0.001 dmDys vs. WT under the same condition.
Found at: doi:10.1371/journal.pone.0013450.s011 (0.02 MB
PDF)
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